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LETTERS TO THE EDITOR
Home dialysis, garbage, and
privacy: Nothing is trivial in
home hemodialysis
To the Editor: The clinical and economic advantages
of home hemodialysis are increasingly recognized [1–3].
Its rediscovery confronted us with new problems, one
of which has never extensively reported: waste material
[4]. In 2000, we added waste disposal to our all-inclusive-
dialysis service to avoid environmental contaminations,
and with the intention of reducing the psychologic burden
of dealing with blood-stained waste.
In a periodic reorganization, we realized that 5 patients
out of 32 had “kindly refused” to use this system, and that
many regretted the time when “everything was just simply
thrown away in the closest garbage can.”
It was our mistake. We were happy when we supplied
our patients with hermetic boxes to safely store dispos-
ables of 3 to 4 sessions, and did not consider the psy-
chologic burden of a small truck with something like
“Ecological system, waste disposables” written on the
flank parking in front of the house, and of an orange-
dressed garbage man coming to pick up containers with
marks on the side reading “Warning,” and “Contains
blood.”
While patients’ criticism is now leading to the devel-
opment of an “anonymous” waste retrieval system, this
episode suggests to all those who have not yet thought
about it, choosing a more privacy-sensible system; it high-
lights how often we physicians forget something impor-
tant when home care is concerned; it underlines that
privacy may be an important deterrent for home dial-
ysis. Lastly, the delay by which we realized this problem
suggests that we should have more time to talk about
simple, practical issues such as garbage cans, too often
considered trivial by those who are healthy.
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A decline in residual
glomerular filtration during the
use of icodextrin may be due to
underhydration
To the Editor: It has become increasingly clear that
overhydration is common in peritoneal dialysis (PD) pa-
tients, which may play a pivotal role in the high prevalence
of hypertension and left ventricular hypertrophy in this
population. We recently reported that more than 30%
of PD patients, treated with conventional glucose solu-
tions, had a normalized extracellullar water (ECW) above
the 90th percentile of stable renal transplant patients
[1].
In a recent randomized study, we reported a signifi-
cant decline in ECW, assessed by the bromide dilution
method, and left ventricular mass in PD patients af-
ter 4 months of treatment with icodextrin 7.5% for the
long dwell. However, in the group treated with icodex-
trin, a significant decline in residual glomerular filtration
(rGFR) was observed [2].
An improvement in fluid status after treatment with
icodextrin was also reported in the randomized study
performed by Davies et al [3]. However, in contrast to
our findings, Davies et al did not observe a reduction in
rGFR.
The main methodologic differences between the two
papers are that Davies et al studied patients with a resid-
ual diuresis below 750 mL, high solute transport, and ei-
ther treated hypertension or untreated BP >140/90 mm
Hg, and compared icodextrin with glucose 2.27% glucose
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solutions for the long dwell. In contrast, we compared
icodextrin with glucose 1.36% in patients without clini-
cal signs of overhydration, of whom the great majority
had significant residual renal function (mean rGFR at
start 4.8 ± 3.2 mL/min). At that time, 1.36% solutions
were used in our clinics for the long dwell in patients in
patients with significant residual diuresis without clinical
signs of overhydration.
In search for an explanation for the discrepancies be-
tween the two studies, we hypothesized that icodextrin
might have led to underhydration in some of our patients.
Therefore, we compared the decline in rGFR between pa-
tients whom were underhydrated at the end of the study
and those who were not. Underhydration was defined as
a normalized ECW (ECW:height) below the 10th per-
centile of the stable renal transplant patients studied in
[1] [<7.8 L/m in males and <7.0 L/m in females].
Four of the 19 patients in the icodextrin-treated group
who completed the study fulfilled this criterion. Com-
pared to the 13 patients treated with icodextrin who were
not underhydrated after completion of the study, the fall
in rGFR tended to be larger [−3.2 ± 2.4 mL/min vs −1.0
± 1.6 mL/min; P = 0.055]. When the underhydrated pa-
tients were excluded from analysis, the decline in rGFR
between patients treated with icodextrin and the control
group was comparable [−1.0 ± 1.6 vs –0.6 ± 0.8 mL/min;
P = 0.6].
In conclusion, the decline in rGFR observed in our
previous study after treatment with icodextrin may have
been due to underhydration in a minority of patients.
Given the limited number of patients in whom underhy-
dration was diagnosed, this assumption needs to be con-
firmed. However, when using icodextrin in patients with
significant residual renal function without clinical signs of
overhydration, objective assessment of fluid status may
be helpful in defining treatment targets [4].
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Arterial stiffness in patients
with kidney transplantation
To the Editor: We read the recent article by Bahous et
al demonstrating tobacco consumption and acute rejec-
tion modulates both aortic stiffness and renal functional
deterioration after kidney transplantation [1]. We wish to
raise several points that can be considered.
Primary end points, including doubling serum creati-
nine (4 patients) and/or new cardiovascular events (9 pa-
tients), which are both independent situations resulting
from different factors, seem to be confusing. In this study
design, one cannot properly expect that the pulse wave
velocity (PWV), mean 54.1 months after the transplan-
tation, can be used as an indicator of the cardiovascular
disease (CVD) after the transplantation. We do not know
the level of PWV before the transplantation; the patients
dying after the transplantation did not have the results
(12 patients), which could affect the analysis. Also, 9 pa-
tients had new CVD, and 6 of them had previous CVD.
It could have been important to see these patients’ PWV
results (9 patients). It is not logical to take serum crea-
tinine into analysis of primary end points (according to
the definition of primary end points). However, it could
be interesting to see whether kidney function, as a risk
factor for CVD, might be also a risk factor for CVD after
the transplantation [2].
Tobacco consumption was given in Table 1. However,
how many patients were using tobacco in both groups?
How many of them were ex-smokers or recent smokers?
The mean pack-year given in Table 1 demonstrated how
many patients?
Also, in Table 2, transplant age (months) was given as
mean 54.1 ± 29.2 for entire, mean 42.5 ± 18.2 for subjects
with positive end points, mean 38 ± 13.5 for patients with
negative end points. It should be corrected.
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